TRINETRA › Sectors › Consumer Services
Entero Healthcare Solutions Limited (ENTERO) — share price, P/E and fundamentals
Entero Healthcare Solutions Limited (NSE: ENTERO) closed at ₹1,565.00 on 30 Oct 2026, +41.4% over one year, against a 52-week range of ₹944.00 – ₹1,920.00.
In the quarter ended 30 Jun 2026 (consolidated, filed 7 Aug 2026) it reported revenue of ₹1,940 cr and net profit of ₹38 cr, a 2.0% net margin; revenue grew 38.2% and profit grew 84.6% year on year.
On four consecutive filed quarters its trailing P/E is 54.3; since 27 May 2025 its own P/E has ranged from 38.6 to 67.0 (median 50.7), and today's reading is higher than 72% of those 353 trading days.
From the balance sheet dated 31 Mar 2026: return on equity 9.0%, ROCE 17.4%, debt-to-equity 0.34, Piotroski F-score 5 of 9.
Against 40 Consumer Services peers on NSE: Net margin higher than 28% of 40 sector peers; PBT margin higher than 30% of 40 sector peers; ROE higher than 46% of 40 sector peers.
Key figures
| Last close | ₹1,565.00 (30 Oct 2026) |
|---|---|
| Change 1 month / 6 months / 1 year | -15.5% / +25.2% / +41.4% |
| 52-week low – high | ₹944.00 – ₹1,920.00 |
| Market capitalisation | ₹6,811 cr |
| Trailing P/E | 54.3 |
| Price / book | 4.03 |
| EV / EBITDA | 22.5 |
| Earnings yield | 1.8% |
| TTM EPS | ₹28.81 |
| TTM net profit | ₹125 cr |
| Quarter revenue | ₹1,940 cr |
| Quarter net profit | ₹38 cr |
| Net margin | 2.0% |
| Revenue growth (YoY) | +38.2% |
| Profit growth (YoY) | +84.6% |
| Return on equity | 9.0% |
| ROCE | 17.4% |
| Debt / equity | 0.34 |
| Current ratio | 1.58 |
| Free cash flow | ₹29 cr |
| Piotroski F-score | 5 / 9 |
| Average daily turnover (50 days) | ₹20.6 cr |
Against Consumer Services peers
| Metric | ENTERO | Peer median | Percentile |
|---|---|---|---|
| Net margin | 1.97 | 5.98 | 28 |
| PBT margin | 3.46 | 8.62 | 30 |
| ROE | 9.04 | 10.15 | 46 |
| ROCE | 17.43 | 12.16 | 68 |
| Debt / equity | 0.34 | 0.09 | 73 |
| Cash conversion | 0.66 | 1.42 | 18 |
| Trailing P/E | 54.31 | 47.66 | 63 |
| P/B | 4.03 | 5.22 | 35 |
Questions
What is the P/E ratio of Entero Healthcare Solutions Limited?
Entero Healthcare Solutions Limited's trailing P/E is 54.3, using the close of 30 Oct 2026 and earnings over the four filed quarters to 30 Jun 2026. Since 27 May 2025 its P/E has ranged 38.6–67.0.
What were Entero Healthcare Solutions Limited's latest quarterly results?
For the quarter ended 30 Jun 2026, Entero Healthcare Solutions Limited reported revenue of ₹1,940 cr and net profit of ₹38 cr (consolidated), filed with the exchange on 7 Aug 2026.
What is Entero Healthcare Solutions Limited's ROE?
Return on equity is 9.0% based on the balance sheet dated 31 Mar 2026.
Does Entero Healthcare Solutions Limited have debt?
Debt-to-equity is 0.34 on the balance sheet dated 31 Mar 2026.
What is ENTERO's 52-week high and low?
Over the last 52 weeks to 30 Oct 2026, ENTERO traded between ₹944.00 and ₹1,920.00.
Other Consumer Services stocks
- ETERNAL LIMITED (ETERNAL)
- Avenue Supermarts Limited (DMART)
- Trent Limited (TRENT)
- Lenskart Solutions Limited (LENSKART)
- The Indian Hotels Company Limited (INDHOTEL)
- Meesho Limited (MEESHO)
- FSN E Commerce Ventures Limited (NYKAA)
- Info Edge (India) Limited (NAUKRI)
- Swiggy Limited (SWIGGY)
- Vishal Mega Mart Limited (VMM)
- Physicswallah Limited (PWL)
- Indian Railway Catering And Tourism Corporation Limited (IRCTC)
Source: consolidated SEBI Integrated Filing for the quarter ended 30 Jun 2026 and NSE daily closes. Open the interactive terminal view for charts and the full statements.
TRINETRA is a research and education tool. Nothing on this site is investment advice or a recommendation to buy or sell any security. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing. Figures are as filed with NSE/SEBI and as of the dates shown; they are not live prices.